Hibiclens Chlorhexidine Gluconate 4 g/100mL Solution, 118 mL
by Molnlycke Health Care · 118 mL in 1 BOTTLE (0234-0575-40)
NDC 00234-0575-40
🏷️ FDA NDC (as labeled)
0234-0575-40
billing pads the labeler segment with a zero
This package
Contains118 mL
Pack sizes9 compare ↓
Also comes in:
50 packets 00234-0575-17
118 ml 00234-0575-41
118 ml 00234-0575-04
236 ml 00234-0575-80
236 ml 00234-0575-08
473 ml 00234-0575-16
946 ml 00234-0575-32
3790 ml 00234-0575-91
OTC
Brand
On market
Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
0234-0575-40
Product NDC
0234-0575
11-digit billing NDC
00234057540
NCPDP billing unit
ML — per mL (volume)
UNII
MOR84MUD8E
Application #
NDA017768
SPL Set ID
29b547bf-c08e-14c2-e054-00144ff88e88
Physiologic effect
Decreased Cell Wall Integrity
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
1976-09-17
Route
TOPICAL
Dosage form
SOLUTION
Substance
CHLORHEXIDINE GLUCONATE
GPI-14
92100030102020
GPI class
Hibiclens
GCN Seq No
007254
GCN
30011
HICL code
004297
Ingredient (HICL)
Chlorhexidine Gluconate
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q5
Therapeutic class — intermediate (HIC2)
Agents Acting Principally On The Skin
HIC3 code
Q5B
Therapeutic class — specific (HIC3)
Topical Preparations,Antibacterials
AHFS code
08:30.04.00
AHFS class
Amebicides
FDB label name
HIBICLENS 4% LIQUID
FDB brand name
Hibiclens
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0234-0575-40 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00234-0575-40. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Antiinfectives and antiseptics for local oral treatment class.
Drug family (ATC)
Antiinfectives and antiseptics for local oral treatment, Antiinfectives, Biguanides and amidines
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerMolnlycke Health Care
Application holderMOLNLYCKE HEALTH CARE
FDA applicationNDA017768 (NDA)
Labeler code00234
First marketedSep 1976
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name HIBICLENS 4% LIQUID Ingredient Chlorhexidine Gluconate
📗 Our plain-language guide HelloPharmacist
- It's actually a prescription-strength antimicrobial rinse, which is different from over-the-counter mouthwash. Your dentist prescribes it specifically to treat gingivitis — that's...
- What exactly is chlorhexidine rinse for — is it just like a regular mouthwash?
- Yes, tooth and surface staining is one of the most common side effects of chlorhexidine oral rinse. It can also increase tartar buildup on your teeth. The good news is that this is...
- My teeth look like they're staining — is that from the rinse?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Chlorhexidine Gluconate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
red
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII WQ29KQ9POT
Gluconolactone is a mild organic acid derived from glucose. It functions as a buffer and pH regulator in medicines, helping maintain stable acidity levels and improve product stability.
-
UNII ND2M416302
Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
-
UNII 4F6FC4MI8W
Lauramine oxide is a surfactant, a substance that helps mix oil and water together. It's used in medicines to improve how ingredients blend and to help the product dissolve or spread properly.
-
UNII JT3U72U71K
A synthetic polymer made from ethylene oxide and propylene oxide. Used as a surfactant and emulsifier to help blend oil and water-based ingredients, and as a thickening agent in liquid formulations.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
6 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesfragrance, gluconolactone, isopropyl alcohol 4% w/v, lauramine oxide, poloxamer 237, purified water and red 40
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Antiseptic Skin Cleanser 4 g/100mL 70000-0407-01 | Cardinal | 237 ml | $0.025 | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 00116-1061-04 | Xttrium | 118 ml | $0.034 | — | Availability likely | — |
| Antiseptic Skin Cleanser 4 mg/100mL 46122-0137-34 | AmerisourceBergen | 237 ml | $0.037 | — | Availability likely | — |
| Foster and Thrive 4 g/100mL 70677-1221-01 | McKesson | 237 ml | $0.037 | — | Availability likely | — |
| Chlorhexidine Gluconate 40 mg/mL 16571-0111-12 | Rising | 118 ml | $0.041 | — | Availability likely | — |
| Betasept .04 mg/mL 67618-0200-04 | Atlantis | 118 ml | $0.041 | — | Availability likely | — |
| Cardinal Health 4 g/100mL 00116-0061-04 | Xttrium | 118 ml | — | — | Discontinued | — |
| Antiseptic Skin Cleanser 4 mg/100mL 00116-0137-34 | Xttrium | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 00116-0161-08 | Xttrium | 237 ml | — | — | FDA listed | — |
| Betasept .04 mg/mL 00116-0200-01 | Xttrium | 3785 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 00116-0401-50 | Xttrium | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 00116-0407-01 | Xttrium | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 00116-0767-08 | Xttrium | 237 ml | — | — | FDA listed | — |
| CliniClean 4 g/100mL 00116-0901-05 | Xttrium | 118 ml | — | — | Discontinued | — |
| Dyna-Hex 4 4 g/100mL 00116-1060-18 | Xttrium | 535 ml | — | — | FDA listed | — |
| Foster and Thrive 4 g/100mL 00116-1221-01 | Xttrium | 237 ml | — | — | FDA listed | — |
| Bactoshield CHG 40 mg/mL 00116-1344-08 | Xttrium | 3780 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 00116-3678-07 | Xttrium | 473 ml | — | — | FDA listed | — |
| Hibiclens 4 g/100mLthis 00234-0575-40 | Molnlycke | 118 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 00363-1061-08 | Walgreen | 237 ml | — | — | FDA listed | — |
| Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% 40 mg/mL 00404-0219-01 | Henry | 118 ml | — | — | FDA listed | — |
| Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% 40 mg/mL 00404-0220-03 | Henry | 236 ml | — | — | FDA listed | — |
| Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% 40 mg/mL 00404-0221-04 | Henry | 473 ml | — | — | FDA listed | — |
| Bactoshield CHG 40 mg/mL 11084-0039-03 | SC | 118 ml | — | — | FDA listed | — |
| Bactoshield CHG 40 mg/mL 11084-0128-03 | SC | 118 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 11822-0116-05 | Rite | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 11822-0891-02 | Rite | 532 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 11822-3678-07 | Rite | 473 ml | — | — | FDA listed | — |
| BD E-Z Scrub 107 40 g/1000mL 17271-0107-03 | Becton | 18 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 36800-0401-50 | Topco | 237 ml | — | — | FDA listed | — |
| Halyard Chlorhexidine Gluconate 40 mg/mL 39892-0960-01 | Owens | 118 ml | — | — | FDA listed | — |
| Halyard Chlorhexidine Gluconate 40 mg/mL 39892-0961-01 | Owens | 118 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 41250-0162-08 | Meijer | 237 ml | — | — | Discontinued | — |
| Scrub, Scrub-Stat, Foam Safe, Micro-Guard 40 mg/mL 42939-0125-19 | AVA, | 946 ml | — | — | FDA listed | — |
| Scrub, Scrub-Stat, Foam Safe, Micro-Guard 40 mg/mL 42939-0128-01 | AVA, | 118 ml | — | — | FDA listed | — |
| Scrub-Stat 40 mg/mL 47593-0464-11 | Ecolab | 3780 ml | — | — | FDA listed | — |
| Scrub-Stat 40 mg/mL 47593-0468-21 | Ecolab | 208000 ml | — | — | Discontinued | — |
| Antiseptic Skin Cleanser 4 g/100mL 59779-0767-08 | CVS | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 mg/100mL 63868-0940-08 | Chain | 237 ml | — | — | FDA listed | — |
| Antiseptic Skin Cleanser 4 g/100mL 68599-5401-00 | McKesson | 4 bottles | — | — | FDA listed | — |
| CliniClean 4 g/100mL 69464-0901-05 | HR | 118 ml | — | — | Discontinued | — |
| Hibiclens 4 g/100mL 76420-0535-08 | Asclemed | 236 ml | — | — | FDA listed | — |
| Surgical Scrub Brush/Sponge With Nail Cleaner 4% CHG 4 g/100mL 84128-0003-01 | Xinxiang | 30 patches | — | — | FDA listed | — |
About this product: this is the brand-name version. Some generic versions are approved by the FDA, but we could not confirm current pharmacy availability from our pricing/market data.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
1976
On the market since
Sep 1976
📍
2026
Currently FDA-listed
50 years listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed
The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Chlorhexidine Gluconate (matched by generic name) — the program that covers self-administered drugs. 7 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Chlorhexidine Gluconate. CMS lists 2 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.96M
Claims incl. refills
658.9K
Beneficiaries
540.1K
Spend / beneficiary
$7.34
Spend / claim
$6.02
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Hibiclens (this brand).
Top reported reactions
Reporter sex
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00234-0575-40 You're viewing this | 118 mL in 1 BOTTLE (0234-0575-40) | 2016-02-15 | Active |
| 00234-0575-41 | 118 mL in 1 BOTTLE, PUMP (0234-0575-41) | 2019-02-01 | Active |
| 00234-0575-80 | 236 mL in 1 BOTTLE, PUMP (0234-0575-80) | 2024-01-01 | Active |
| 00234-0575-17 | 50 PACKET in 1 CARTON (0234-0575-17) / 15 mL in 1 PACKET | 1976-09-17 | Active |
| 00234-0575-04 | 118 mL in 1 BOTTLE (0234-0575-04) | 1976-09-17 | Active |
| 00234-0575-08 | 236 mL in 1 BOTTLE (0234-0575-08) | 1976-09-17 | Active |
| 00234-0575-16 | 473 mL in 1 BOTTLE (0234-0575-16) | 1976-09-17 | Active |
| 00234-0575-32 | 946 mL in 1 BOTTLE (0234-0575-32) | 1976-09-17 | Active |
| 00234-0575-91 | 3790 mL in 1 BOTTLE (0234-0575-91) | 1976-09-17 | Active |
Pack size FAQ
What quantity is in NDC 00234-0575-40?
NDC 00234-0575-40 contains 118 mL — 118 ml in 1 bottle.
What is the difference between NDC 00234-0575-40 and NDC 00234-0575-41?
Both are Hibiclens Chlorhexidine Gluconate 4 g/100mL Solution — the drug itself is identical. NDC 00234-0575-40 is the 118 mL package, while NDC 00234-0575-41 is the 118 ml package.
What NDC number is used to bill for this package of Hibiclens Chlorhexidine Gluconate 4 g/100mL Solution?
Bill NDC 00234-0575-40 — the 11-digit billing format is 00234057540. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0234-0575-40, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00234-0575-40, written without dashes as 00234057540. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00234-0575-40, the first segment (00234) is the labeler code FDA assigned to Molnlycke Health Care; the middle segment (0575) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (40) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Molnlycke Health Care. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 8 other package presentations of this same product, including 50 packets (00234-0575-17), 118 ml (00234-0575-41), 118 ml (00234-0575-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Molnlycke Health Care is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses antimicrobial skin cleanser helps reduce bacteria that potentially can cause disease for skin wound and general skin cleansing surgical hand scrub healthcare personnel handwash
⏱️ Dosage and Administration ▾
Directions use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. skin wound and general skin cleansing. Thoroughly rinse the area to be cleansed with water.
Apply the minimum amount of the product necessary to cover the skin or wound area and wash gently. Rinse thoroughly. surgical hand scrub. Wet hands and forearms with water.
Scrub for 3 minutes with about 5 mL (4 pumps) of the product with a brush. Rinse thoroughly under running water. Repeat.
Dry thoroughly. healthcare personnel handwash. Wet hands with water. Dispense about 5 mL (4 pumps) of the product into cupped hands and wash in a vigorous manner for 15 seconds.
Rinse and dry thoroughly.
⚠️ Warnings ▾
Warnings For external use only
Allergy alert: This product may cuase a severe allergic reaction. Symptoms may include: wheezing/difficulty breathing shock facial swelling hives rash If an allergic reaction occurs, stop use and seek medical help right away.
🧪 Active Ingredient ▾
Chlorhexidine gluconate solution 4.0% w/v
🧪 Inactive Ingredients ▾
Inactive ingredients fragrance, gluconolactone, isopropyl alcohol 4% w/v, lauramine oxide, poloxamer 237, purified water and red 40
🎯 Purpose ▾
Antiseptic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.